Human Cadherin-11 quantitates human Cadherin-11 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human Cadherin-11.
Human Cadherin-11 quantitates human Cadherin-11 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human Cadherin-11.
This gene codes a classic II cadherin from the cadherin superfamily, integral membrane proteins that mediate cell adhesion to calcium-dependent cells. All cadherins are single-pass transmembrane proteins with a variable number of fields of extracellular cadherin (EC) at 110 amino acids. The classical cadherins consist of five large EC domains at the N-terminal end, one domain spanning the membrane and a small highly conserved C-terminal cytoplasmic domain. Based on amino acid alignment, conventional cadherins are divided into Type I and Type II subgroups. Type I cadherins, including cadherins E (epithelial), N (neural), P (placental) and R (retinal), differ from type I cadherins in their specific amino acid sequences. II cadherins include cadherin-5, -6, -8, -11, and -12. II cadherins are defined based on their absence of a HAV cell adhesion recognition sequence specific to Type I cadherins. Cadherin-11 (OB-cadherin) is a marker of the migratory and weakly connected cellular elements of mesenchyma. A strong expression of cadherin-11 has been observed in the brain, spinal cord, bone marrow and bone cells, and is regulated in the epithelial and stromal cells of human endometrial glands. The expression of this particular cadherin in osteoblastic cell lines and its regulation during differentiation suggests a specific function in bone development and maintenance. A variant of the cadherin-11 gene (alternative form) encodes a truncated protein with an unusual cytoplasmic domain that is not present in other cadherins. The variant protein is generated by alternative splicing, using an intronic sequence of 179 bp. Recently, expression of mRNA and cadherin-11 protein was identified in most of the invasive breast cancer cell lines tested, but not in non-invasive cell lines, suggesting that cadherin-11 may be a marker for aggressive and invasive tumour subsets.
Sensitivity
Sensitivity of dosage: 0.8 pg/ml.
Measurement range
Dose range: 0.8 to 200 ng/ml.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Samples
Type of sample: Plasma, Serum, Surnatant (Serum volume, 50 µl; plasma, 50 µl; supernatant, 50 µl).
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 17195289 |
| Specifications |
| Accession number | CAD11; Cad-11; cadherin; cadherin 11; cadherin 11, Type 2, cadherin-OB (osteoblast); cadherin-11; Cdh11; CDHOB; OB; cadherin OB; cadherin-OB; OSF-4; osteoblast cadherin; cadherin-osteoblast |
| Dose range | 0.8 to 200 ng/ml |
| Sensitivity of the dosage | 0.8 pg/ml |
| Conjugate | Biotin |
| Product type | ELISA |
| Type of sample | Plasma, Serum, Surnatant |
| For use with (equipment) | Colorimetric microplate reader |
| Genetic identification (Enter) | P55287 |
| Gene symbol(s) | CDH11 |
| Coefficient of inter-dose variation | <12% |
| Coefficient of intra-dose variation | <10% |
| Contents of kits | 96 pre-coated well plate, standard, dosing diluent concentrate, biotinylated detection antibody, SAV-HRP, washing pad, chromogen, stop solution, adhesive plate lids |
| Marker or dye | HRP |
| Quantity | 5 x 96 tests |
| Regulatory status | Use exclusively for research |
| Target | CDH11 |
| Test time | 1 h 20 min |
| Physical characteristics |
| Volume of sample | Serum, 50 µl; plasma, 50 µl; supernatant, 50 µl |
| Storage and shipping |
| Storage conditions | 2°C to 8°C |
| Total duration of dosing | 4 h 45 min |
Origin and customs
| Manufacturer ref. | EH61RBX5 |
|---|
| Country of origin | United States |
|---|
A question or a specific configuration?
Contact us for a quote.